Education
About Us
Working with TipRanks
Follow Us
Outset Medical (OM)
NASDAQ:OM
OM Stock Chart & Stats
$5.01
-$0.10(-9.09%)
At close: 4:00 PM EST
$5.01
-$0.10(-9.09%)
Day’s Range― - ―
52-Week Range$3.10 - $21.98
Previous CloseN/A
Volume1.92M
Average Volume (3M)1.30M
Market Cap
$90.84M
Enterprise Value$57.67M
Total Cash (Recent Filing)$178.64M
Total Debt (Recent Filing)$3.16M
Price to Earnings (P/E)―
Beta1.70
Next Earnings
Feb 11, 2026EPS Estimate
-0.67Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding18,153,090
10 Day Avg. Volume367,767
30 Day Avg. Volume1,299,395
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.15
Price to Sales (P/S)0.51
P/FCF Ratio-0.49
Enterprise Value/Market Cap0.63
Enterprise Value/Revenue0.48
Enterprise Value/Gross Profit1.27
Enterprise Value/Ebitda-0.83
Forecast
1Y Price Target
$11.75Price Target Upside134.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical ValidationNew clinical findings presented at a major nephrology meeting reinforced the effectiveness of insourced dialysis, strengthening the product's clinical credibility.
Console Sales MomentumConsole revenue returned to growth and beat consensus, supporting stronger revenue momentum for the Tablo system.
Margin Improvement And Cash EfficiencyImproved gross margins, lower operating expenses, and minimal cash burn point to better profitability and financial discipline.
Bears Say
Consumables Demand MismatchWeakness in consumables sales driven by a disconnect between orders and actual usage pressures recurring revenue streams.
Revenue Execution And Order-timing RiskReported revenue missed analyst consensus and recurring revenue was flat year over year, highlighting execution and order-timing risks.
Sales Leadership TurnoverDeparture of the head of sales introduces potential salesforce disruption that could hinder deal execution and customer engagement.
Outset Medical News
OM FAQ
What was Outset Medical’s price range in the past 12 months?
Outset Medical lowest stock price was $3.10 and its highest was $21.98 in the past 12 months.
What is Outset Medical’s market cap?
Outset Medical’s market cap is $90.84M.
When is Outset Medical’s upcoming earnings report date?
Outset Medical’s upcoming earnings report date is Feb 11, 2026 which is in 10 days.
How were Outset Medical’s earnings last quarter?
Outset Medical released its earnings results on Nov 10, 2025. The company reported -$0.69 earnings per share for the quarter, missing the consensus estimate of -$0.655 by -$0.035.
Is Outset Medical overvalued?
According to Wall Street analysts Outset Medical’s price is currently Undervalued.
Does Outset Medical pay dividends?
Outset Medical does not currently pay dividends.
What is Outset Medical’s EPS estimate?
Outset Medical’s EPS estimate is -0.67.
How many shares outstanding does Outset Medical have?
Outset Medical has 18,153,090 shares outstanding.
What happened to Outset Medical’s price movement after its last earnings report?
Outset Medical reported an EPS of -$0.69 in its last earnings report, missing expectations of -$0.655. Following the earnings report the stock price went down -48.467%.
Which hedge fund is a major shareholder of Outset Medical?
Currently, no hedge funds are holding shares in OM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Outset Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.75 (134.53% Upside)
$11.75 (134.53% Upside)
Blogger Sentiment
Bullish
OM Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 15.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $180.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 12.2%
Last 30 Days ▼ 12.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.86%
12-Months-Change
Fundamentals
Return on Equity
-92.33%
Trailing 12-Months
Asset Growth
-5.34%
Trailing 12-Months
Company Description
Outset Medical
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
OM Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook for Outset Medical. While there were positives such as increased console sales, improved gross margins, and a strong cash position, the company faced challenges with revenue growth, leadership changes, and deal closing timing. The uncertainty about future sales leadership and the revision of revenue guidance contributed to a cautious outlook.View all OM earnings summariesOM Revenue Breakdown
47.04% Consoles
32.37% Consumables
20.59% Service and other revenue
OM Stock 12 Month Forecast
Average Price Target
$11.75
▲(134.53% Upside)
Technical Analysis
Ownership Overview
4.15% Insiders
25.62% Mutual Funds
2.80% Other Institutional Investors
58.14% Public Companies and
Individual Investors